ODYSSEY ALTERNATIVE - ODYSSEY ALTERNATIVE

Description:

The current trial sought to study the safety and efficacy of alirocumab, a PCSK9 inhibitor, compared with ezetimibe in patients who were statin intolerant and had an indication for statin use.